Intarcia Moves Headquarters to Boston

Intarcia Therapeutics Inc. , a diabetes drug-device company, has just completed the largest fundraising campaign by a private biotech firm and announced plans to move its headquarters to Boston.

The $210 in new funds will help the firm launch a Phase III program with its potential once-a-year type 2 diabetes treatment ITCA-650 and to complete its move to Boston.

San Francisco Business Times

Shared By

Delores Jackson

Delores Jackson was Director of Corporate Learning for Oklahoma City Community College for eight years, consulting with business leaders to determine the training and develop needs of their employees, designing the programs, and managing a staff of professional trainers. ...

Leave a Comment